Enhanced epidermal langerhans cell migration in IL-10 knockout mice

Journal of Immunology

Volumn 162, Issue 1, 1999, Pages 277-283

  Wang, Binghe ^a   Zhuang, Lihua ^a   Fujisawa, Hiroshi ^a   Shinder, Gayle A ^a   Feliciani, Claudio ^a   Shivji, Gulnar M ^a   Suzuki, Hirotake ^a   Amerio, Paolo ^a   Toto, Paola ^a   Sauder, Daniel N ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELL MIGRATION; CONTACT ALLERGY; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS; HUMAN; IMMUNOMODULATION; KERATINOCYTE; LANGERHANS CELL; MOUSE; PRIORITY JOURNAL;

ANIMALS; CELL COUNT; CELL MOVEMENT; DERMATITIS, CONTACT; EPIDERMIS; FLUORESCEIN-5-ISOTHIOCYANATE; HAPTENS; IMMUNE SERA; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-10; KERATINOCYTES; LANGERHANS CELLS; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032961105     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Austyn, J. M. 1996. New insight into the mobilization and phagocytic activity of dendritic cells, J. Exp. Med. 183:1287.
3. Stingl, G., C. Hauser, and K. Wolff. 1993. The epidermis: an immunologic microenvironment. In Dermatology in General Medicine, 4th Ed. T. B. Fitzpatrick, A. Z. Eisen, K. Wolff, I. M. Freedberg, and K. F. Austen, eds. McGraw-Hill, New York, p. 172.
4. Macatonia, S. E., S. C. Knight, A. J. Edwards, S. Griffiths, and P. Fryer. 1987. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 166:1654.
5. Kripke, M. L., C. G. Munn, A. Jeevan, J. M. Tang, and C. Bucana 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145:2833.
6. Barratt-Boyes, S. M., S. C. Watkins, and O. L. Finn. 1997. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J. Immunol. 158:4543.
7. + T cells. J. Exp. Med. 185:2133.
8. Ma, J., J. H. Wang, Y. J. Guo, M. S. Sy, and M. Bigby. 1994. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell. Immunol. 158:389.
9. 6 Integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 186: 1725.
10. Tang, A., M. Amagai, L. G. Granger, J. R. Staney, and M. C. Udey. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361:82.
11. Weiss, J. M., J. Sleeman, A. C. Renkl, H. Dittmar, C. C. Termeer, S. Taxis, N. Howells, G. Kohler, E. Schopf, H. Ponta, P. Herrlich, and J. C. Simon. 1997. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell. Biol. 137:1137.
12. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J. Immunol. 150:3698.
13. Kimber, I., and M. Cumberbatch. 1992. Stimulation of Langerhans cell migration by tumour necrosis factor-α (TNF-α). J. Invest. Dermatol. 99:48s.
14. Sozzani, S., W. Luini, A. Borsatti, N. Polentarutti, D. Zhou, L. Piemonti, G. D'Amico, C. A. Power, T. N. C. Wells, M. Gobbi, et al. 1997. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 159:1993.
15. Greaves, D. R., W. Wang, D. J. Dairaghi, M. C. Dieu, B. de Saint-Vis, K. Franz-Bacon, D. Rossi, C. Caux, T. McClanahan, S. Gordon, et al. 1997. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells. J. Exp. Med. 186: 837.
16. Roake, J. A., A. S. Rao, P. J. Morris, C. P. Larsen, D. F. Hankins, and J. M. Austyn. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med 181:2237.
17. Caux, C., Y. J. Liu, and J. Banchereau. 1995. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol. Today 16:2.
18. Schreiberg, S., O. Kilgus, E. Payer, R. Kutil, A Elbe, C. Mueller, and G. Stingl. 1992. Cytokine pattern of Langerhans cells isolated from murine epidermal cell culture. J. Immunol. 149:3525.
19. Schwarzenberger, K., and M. C. Udey. 1996. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 106:553.
20. Jokob, T., and M. C. Udey. 1998. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J. Immunol. 160:4067.
21. Enk, A. H., and S. I. Katz. 1992. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA 89:1398.
22. Enk, A. H., and S. I. Katz. 1992. Identification and induction of keratinocyte-derived IL-10. J. Immunol 149:92.
23. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
24. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
25. Howard, M., and A. O'Garra. 1992. Biological properties of interleukin 10. Immunol. Today 13:198.
26. Trip, C. S., S. F. Wolf, E. R. Unanue. 1913. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
27. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041
28. Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
29. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10. J. Immunol. 151:2390.
30. Ferguson, T. A., P. Dube, and T. S. Griffith. 1994. Regulation of contact hyper-sensitivity by interleukin 10. J. Exp. Med. 179:1597.
31. Enk, A. H., J. Saloga, D. Becker, M. Mohamadzadeh, and J. Knop. 1994. Induction of hapten-specific tolerance by interleukin 10 in vitro. J. Exp. Med. 179: 1397.
32. Berg, D. J., M. W. Leach, R. Kuhn, K. Rajewsky, W. Muller, N. J. Davidson, and D. Rennick. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:99.
33. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
34. Wang, B., A. Rieger, O. Kilgus, K. Ochiai, D. Maurer, D. Fodinger, J. P. Kinet, and G. Stingl. 1992. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc∈RI. J. Exp. Med. 175:1353.
35. Vremec, D., M. Zorbas, R. Scollay, D. J. Saunders, C. F. Ardevin, L. Wu, and K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176:47.
36. Cumberbatch, M., and I. Kimber. 1995. Tumor necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84:31.
37. Smith, M. R., W. E. Munger, H. F. Kung, L. Takacs, and S.K. Durum. 1990. Direct evidence for an intracellular role for tumor necrosis factor-α: microinjection of tumor necrosis factor kills target cells. J. Immunol. 144:162.
38. Franks, A. K., K. I. Kujawa, and L. J. Yaffe. 1991. Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival. Infect. Immun. 59:2609.
39. Vidal-Vanaclocha, F., C. Amezaga, A. Asumendi, G. Kaplanski, and C. A. Dinarello. 1994. Interleukin-1 receptor blockage reduces the number and size of murine BI6 melanoma hepatic metastases. Cancer Res. 54:2667.
40. Chirivi, R. G., A. Garofalo, I. M. Padula, A. Mantovani, and R. Giavazzi. 1993. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system. Cancer Res 53:5051.
41. Kondo, S., S. Pastore, H. Fujisawa, G. M. Shivji, R. C. McKenzie, C. A. Dinarello, and D. N. Sander. 1995. Interleukin-1 receptor antagonist suppresses contact hypersensitivity. J. Invest. Dermatol. 105:334.
42. Tang, A., T. A. Judge, B. J. Nickoloff, and L. A. Turka. 1996. Suppression of murine allergic contact dermatitis by CTLA41g. J. Immunol. 157:117.
43. /- mice. J. Immunol. 157:4822.
44. Arock, M., C. Zuany-Amorim, M. Singer, M. Benhamou, and M. Pretolani. 1996. Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 26:166.
45. Sauder, D. N., and M. T. Dytoc. 1997. Cytokines, Curr. Prob. Dermatol. 9:1.
46. Cumberbatch, M., R. J. Dearman, and I. Kimber. 1997. Langerhans cells require signals from both tumor necrosis factor-α and interleukin-1 β for migration. Immunology 92:388.
47. Rambukkana, A., F. H. M. Pistoor, J. D. Bos, M. L. Kapsenberg, and P. K. Das. 1996. Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 β protein. Lab. Invest. 74:422.
48. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185:317.
49. Wang, B., S. Kondo, G. M. Shivji, H. Fujisawa, T. W. Mak, and D. N. Sauder. 1996. Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans cells. Immunology 88: 184.
50. Wang, B., H. Fujisawa, L. Zhuang, S. Kondo, G. M. Shivji, C. S. Kim, T. W. Mak, and D. N. Sauder. 1997. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 159:6148.
51. Bigby, M., R. Vargas, and M.-S. Sy. 1989. Production of hapten-specific T cell hybridomas and their use to study the effect of ultraviolet B irradiation on the development of contact hypersensitivity. J. Immunol. 143:3867.
52. Larsen, C. P., R. M. Steinman, M. Winner-Pack, D. F. Hankins, P. J. Morris, and J. M. Austyn. 1990. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172:1483.
53. Lukas, M., H. Stossel, L. Hefel, S. Imamura, P. Fritsch, N. T. Sepp, G. Schuler, and N. Romani. 1996. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J. Invest. Dermatol. 106:1293.